• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒性肝炎感染和死亡率负担:2009年至2023年波兰一项基于人群研究的结果

The burden of viral hepatitis infection and mortality: Findings from a population-based study in Poland over 2009-2023.

作者信息

Genowska Agnieszka, Zarębska-Michaluk Dorota, Brzdęk Michał, Tyszko Piotr, Strukcinskiene Birute, Paradowska-Stankiewicz Iwona, Rzymski Piotr, Flisiak Robert

机构信息

Department of Public Health, Medical University of Bialystok, Bialystok, Poland.

Department of Infectious Diseases and Allergology, Jan Kochanowski University, Kielce, Poland.

出版信息

Clin Exp Hepatol. 2025 Jun;11(2):137-146. doi: 10.5114/ceh.2025.151703. Epub 2025 Jun 26.

DOI:10.5114/ceh.2025.151703
PMID:40904663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12403644/
Abstract

AIM OF THE STUDY

To analyze long-term epidemiological patterns and trends in the burden of infection and mortality due to viral hepatitis in Poland before and during the COVID-19 pandemic.

MATERIAL AND METHODS

Data for the burden of the most common viral hepatitis types (HAV, HBV ±HDV, HCV, and HEV) over 2009-2023 were extracted from the national registries in Poland. The joinpoint regression model was used to analyze trends in viral hepatitis infections and mortality.

RESULTS

The burden of viral hepatitis infection and mortality in Poland changed between 2009 and 2023. Before the COVID-19 pandemic, the trend of newly diagnosed HAV infection was characterized by a sharp increase over 2015-2018 compared to the other types of hepatitis. At the beginning of the COVID-19 pandemic, the burden of infection and mortality among most types of hepatitis showed a change in the direction of the trend from negative to positive, which continued in subsequent years. A pronounced increasing trend for both infection and mortality occurred in the category of other viral hepatitis. Over the whole period of 2009-2023, there was only one decreasing trend for mortality due to HBV infection.

CONCLUSIONS

The findings of the study draw attention to the noticeable impact of the COVID-19 pandemic on the burden of viral hepatitis in Poland, which threatens to disrupt the beneficial direction of virus elimination. Trends of viral hepatitis infection and mortality require further monitoring. It is also necessary to increase preventive measures and improve access to diagnostics and the linkage to health care.

摘要

研究目的

分析波兰在新冠疫情之前及期间,病毒性肝炎感染负担和死亡率的长期流行病学模式及趋势。

材料与方法

从波兰国家登记处提取2009 - 2023年最常见病毒性肝炎类型(甲型肝炎病毒、乙型肝炎病毒±丁型肝炎病毒、丙型肝炎病毒和戊型肝炎病毒)的负担数据。采用连接点回归模型分析病毒性肝炎感染和死亡率的趋势。

结果

2009年至2023年期间,波兰病毒性肝炎感染负担和死亡率发生了变化。在新冠疫情之前,与其他类型肝炎相比,2015 - 2018年期间新诊断甲型肝炎病毒感染呈急剧上升趋势。在新冠疫情初期,大多数肝炎类型的感染和死亡率负担趋势方向从负变正,并在随后几年持续。其他病毒性肝炎类别中感染和死亡率均呈现明显上升趋势。在2009 - 2023年整个期间,乙型肝炎病毒感染导致的死亡率仅出现一次下降趋势。

结论

该研究结果提醒人们注意新冠疫情对波兰病毒性肝炎负担产生的显著影响,这可能会扰乱病毒消除的有益方向。病毒性肝炎感染和死亡率趋势需要进一步监测。还必须加强预防措施,改善诊断可及性以及与医疗保健的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/c76bbc30b2d4/CEH-11-56177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/7de16c33272d/CEH-11-56177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/aee7c9ae510e/CEH-11-56177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/c76bbc30b2d4/CEH-11-56177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/7de16c33272d/CEH-11-56177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/aee7c9ae510e/CEH-11-56177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/953a/12403644/c76bbc30b2d4/CEH-11-56177-g003.jpg

相似文献

1
The burden of viral hepatitis infection and mortality: Findings from a population-based study in Poland over 2009-2023.病毒性肝炎感染和死亡率负担:2009年至2023年波兰一项基于人群研究的结果
Clin Exp Hepatol. 2025 Jun;11(2):137-146. doi: 10.5114/ceh.2025.151703. Epub 2025 Jun 26.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
4
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
5
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
6
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
7
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.尼日利亚丁型肝炎病毒的流行率、危险因素及临床特征:一项2009 - 2024年的系统综述
Viruses. 2024 Oct 31;16(11):1723. doi: 10.3390/v16111723.

本文引用的文献

1
Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection.《像滚石一样?关于丙型肝炎病毒感染自发清除的综述》。
Viruses. 2024 Aug 30;16(9):1386. doi: 10.3390/v16091386.
2
Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.预防性丙型肝炎疫苗还有希望吗?不同方法的综述。
J Med Virol. 2024 Sep;96(9):e29900. doi: 10.1002/jmv.29900.
3
The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.COVID-19 大流行(2020-2023 年)及俄乌战争移民期间和之后的传染病负担。
J Med Virol. 2024 May;96(5):e29651. doi: 10.1002/jmv.29651.
4
Trends of Hepatitis A Virus Infection in Poland: Assessing the Potential Impact of the COVID-19 Pandemic and War in Ukraine.波兰甲型肝炎病毒感染趋势:评估 COVID-19 大流行和乌克兰战争的潜在影响。
Viruses. 2024 Mar 20;16(3):469. doi: 10.3390/v16030469.
5
Trends of infections and mortality due to hepatitis B virus (2005-2022) and the potential impact of the COVID-19 pandemic: a population-based study in Poland.乙型肝炎病毒导致的感染和死亡率趋势(2005 - 2022年)以及新冠疫情的潜在影响:波兰一项基于人群的研究
Clin Exp Hepatol. 2023 Sep;9(3):286-296. doi: 10.5114/ceh.2023.131225. Epub 2023 Sep 22.
6
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.欧洲的乙型肝炎和丙型肝炎:来自 2019 年全球疾病负担研究的最新更新。
Lancet Public Health. 2023 Sep;8(9):e701-e716. doi: 10.1016/S2468-2667(23)00149-4.
7
Changing Epidemiological Patterns of Infection and Mortality Due to Hepatitis C Virus in Poland.波兰丙型肝炎病毒感染及死亡的流行病学模式变化
J Clin Med. 2023 Jun 8;12(12):3922. doi: 10.3390/jcm12123922.
8
Hepatitis E vaccine-Illuminating the barriers to use.戊型肝炎疫苗——揭示使用障碍
PLoS Negl Trop Dis. 2023 Jan 5;17(1):e0010969. doi: 10.1371/journal.pntd.0010969. eCollection 2023 Jan.
9
Securing wider EU commitment to the elimination of hepatitis C virus.争取欧盟更广泛地承诺消除丙型肝炎病毒。
Liver Int. 2023 Feb;43(2):276-291. doi: 10.1111/liv.15446. Epub 2022 Dec 14.
10
A Review of HDV Infection.丁型肝炎病毒感染综述
Viruses. 2022 Aug 10;14(8):1749. doi: 10.3390/v14081749.